22 participants
Regorafenib, With Cetuximab or Panitumumab, for the Treatment of Unresectable, Locally Advanced, or Metastatic Colorectal Cancer
- Study Type:
- INTERVENTIONAL
- Last Updated:
- 2024-09-27
- Start Date:
- 2020-03-03
- Completion:
- 2023-09-05
Conditions
- BRAF V600E Negative
- KRAS Gene Mutation Negative
- Locally Advanced Unresectable Colorectal Adenocarcinoma
- Metastatic Colorectal Adenocarcinoma
- NRAS Gene Mutation Negative
- Stage III Colorectal Cancer AJCC v8
- Stage IIIA Colorectal Cancer AJCC v8
- Stage IIIB Colorectal Cancer AJCC v8
- Stage IIIC Colorectal Cancer AJCC v8
- Stage IV Colorectal Cancer AJCC v8
- Stage IVA Colorectal Cancer AJCC v8
- Stage IVB Colorectal Cancer AJCC v8
- Stage IVC Colorectal Cancer AJCC v8
Interventions
- BIOLOGICAL
- DRUG